Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 12 results.
User Information
Export Records
  1. 1.   Allogeneic Hematopoietic Stem-Cell Transplantation for GATA2 Deficiency Using a Busulfan-Based Regimen
  2. Parta, Mark; Shah, Nirali N; Baird, Kristin; Rafei, Hind; Calvo, Katherine R; Hughes, Thomas; Cole, Kristen; Kenyon, Meg; Blacklock Schuver, Bazetta; Cuellar-Rodriguez, Jennifer; Zerbe, Christa S; Holland, Steven M; Hickstein, Dennis D
  3. Biology of Blood and Marrow Transplantation. 2018, Jun; 24(6): 1250-1259.
  1. 2.   Differential effects of donor T-cell cytokines on outcome with continuous bortezomib administration after allogeneic bone marrow transplantation
  2. Sun, K.; Li, M. H.; Sayers, T. J.; Welniak, L. A.; Murphy, W. J.
  3. Blood. 2008 112(4): 1522-1529.
  1. 3.   Peyer patches are not required for acute graft-versus-host disease after myeloablative conditioning and murine allogeneic bone marrow transplantation
  2. Welniak, L. A.; Kuprash, D. V.; Tumanov, A. V.; Panoskaltsis-Mortari, A.; Blazar, B. R.; Sun, K.; Nedospasov, S. A.; Murphy, W. J.
  3. Blood. 2006, JAN 1; 107(1): 410-412.
  1. 4.   Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity
  2. Sun, K.; Wilkins, D. E. C.; Anver, M. R.; Sayers, T. J.; Panoskaltsis-Mortari, A.; Blazar, B. R.; Weiniak, L. A.; Murphy, W. J.
  3. Blood. 2005, NOV 1; 106(9): 3293-3299.
  1. 5.   Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking
  2. Chen, X.; Murakami, T.; Oppenheim, J. J.; Howard, O. M. Z.
  3. Blood. 2005, OCT 1; 106(7): 2409-2416.
  1. 6.   Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease
  2. Gendelman, M.; Hecht, T.; Logan, B.; Vodanovic-Jankovic, S.; Komorowski, R.; Drobyski, W. R.
  3. Journal of Immunology. 2004 172(5): 3328-3336.
  1. 7.   An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease
  2. Welniak, L. A.; Wang, Z.; Sun, K.; Kuziel, W.; Anver, M. R.; Blazar, B. R.; Murphy, W. J.
  3. Experimental Hematology. 2004 32(3): 318-324.
  1. 8.   Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib
  2. Sun, K.; Welniak, L. A.; Panoskaltsis-Mortari, A.; O'Shaughnessy, M. J.; Liu, H. Y.; Barao, I.; Riordan, W.; Sitcheran, R.; Wysocki, C.; Serody, J. S.; Blazar, B. R.; Sayers, T. J.; Murphy, W. J.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(21): 8120-8125.
  1. 9.   The absence of Peyer's patches or host TNF-alpha does not affect GVHD progression in an allogeneic BMT model using extensive conditioning regimens
  2. Welniak, L. A.; Kuprash, D. V.; Tumanov, A. V.; Sun, K.; Stull, S. W.; Anver, M. R.; Nedospasov, S. A.; Murphy, W. J.
  3. Biology of Blood and Marrow Transplantation. 2004 10(2, Suppl. 1): 52-52.
  1. 10.   Adoptive cellular immunotherapy: NK cells and bone marrow transplantation
  2. Koh, C. Y.; Welniak, L. A.; Murphy, W. J.
  3. Histology and Histopathology. 2000 15(4): 1201-1210.
  1. 11.   New strategies for preventing graft-versus-host disease
  2. Murphy, W. J.; Blazar, B. R.
  3. Current Opinion in Immunology. 1999 11(5): 509-515.
  1. 12.   Suppression of Graft-Versus-Host Disease and Amplification of Graft-Versus-Tumor Effects By Activated Natural Killer Cells After Allogeneic Bone Marrow Transplantation
  2. Asai, O.; Longo, D. L.; Tian, Z. G.; Hornung, R. L.; Taub, D. D.; Ruscetti, F. W.; Murphy, W. J.
  3. Journal of Clinical Investigation. 1998 101(9): 1835-1842.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel